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 Genotype-by-Sex Interaction in the Regulation of High-Density
 Lipoprotein: The Framingham Heart Study
 M. J. MOSHER,1 L. J. MARTIN,2 L. A. CUPPLES,3 Q. YANG,3 T. D. DYER,4 J. T. WILLIAMS,4
 AND K. E. NORTH1
 Abstract Low levels of high-density lipoprotein (HDL) are widely docu-
 mented as a risk factor for cardiovascular disease (CVD). Furthermore, there
 is marked sexual dimorphism in both HDL levels and the prevalence of
 CVD. However, the extent to which genetic factors contribute to such dimor-
 phism has been largely unexplored. We examined the evidence for genotype-
 by-sex effects on HDL in a longitudinal sample of 1,562 participants from
 330 families in the Framingham Heart Study at three times points corre-
 sponding approximately to 1971-1974, 1980-1983, and 1988-1991. Using
 a variance component method, we conducted a genome scan of HDL at each
 time point in males and females, separately and combined, and tested for
 genotype-by-sex interaction at a quantitative trait locus (QTL) at each time
 point. Consistent findings were noted only for females on chromosome 2
 near marker D2S1328, with adjusted LOD scores of 2.6, 2.2, and 2.1 across
 the three time points, respectively. In males suggestive linkage was detected
 on chromosome 16 near marker D16S3396 at the second time point and
 on chromosome 18 near marker D18S851 at the third time point (adjusted
 LOD = 2.2 and 2.4, respectively). Although the heritability of HDL is simi-
 lar in males and females, sex appears to exert a substantial effect on the
 QTL-specific variance of HDL. When genotype-by-sex interactions exist and
 are not modeled, the power to detect linkage is reduced; thus our results may
 explain in part the paucity of significant linkage findings for HDL.
 Cardiovascular disease (CVD) is the leading cause of death in the United States
 (Arias et al. 2003). A major risk factor for CVD is high-density lipoprotein
 (HDL), identified nearly 30 years ago (Gordon et al. 1977). Since the original
 study, low plasma HDL levels have been associated with a greater prevalence of
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 CVD throughout the world (de Backer et al. 1998). The association between
 HDL and CVD may be explained in part by HDL physiology. HDL, the primary
 constituent of the reverse cholesterol transport system, returns excess cholesterol
 from peripheral tissues to the liver for recycling or excretion. In addition, it medi-
 ates physiological traits connected to endothelial function, possesses antithrom-
 botic properties, inhibits monocyte adhesion to vascular walls, and may act as an
 antioxidant (Barter et al. 2003). However, plasma HDL exhibits striking sexual
 dimorphism, which is expressed as higher HDL levels and lower CVD prevalence
 in females (Reilly et al. 1990; Barrett-Conner 1997). Factors underlying this di-
 morphism are not fully understood.
 HDL is a complex trait influenced by both environment and genes (Wilson
 et al. 1994; Snieder et al. 1997). Environmental factors known to influence
 plasma HDL levels include smoking (Williams 1992), dietary patterns and alco-
 hol intake (Perusse et al. 1997a; Friedlander et al. 2000), glucose metabolism
 (Tall 1990), adiposity (Stevens et al. 1993), sex hormones (Wu and von Eckard-
 stein 2003), and age (Ordovas 2002). From a genetic standpoint a variety of
 family studies have reported that HDL has the highest heritability ( h 2) of the
 lipid subfractions, with estimates ranging from 40% to 70% (Mitchell et al. 1996;
 Duggirala et al. 2000; Hokanson et al. 2003). Genome scans in several popula-
 tions further identified regions of interest linked to HDL levels, although with
 relatively low LOD scores (Ordovas 2002), except for a region on chromosome
 16q21 identified in Mexican Americans with a LOD = 4.3 (Mahaney et al.
 2003).
 One reason that few studies have identified significant linkage to HDL may
 be genotype-by-sex interaction, which, when present, reduces the power to local-
 ize quantitative trait loci (QTLs), although sex-specific QTLs that influence vari-
 ation in HDL levels have been identified in animal studies (Kloting et al. 2001;
 Anunciado et al. 2003; Korstanje et al. 2004a). Recent studies have identified
 sex-specific HDL variation associated with several environmental factors: dietary
 patterns (Mosher et al. 2005; Vega-Lopez et al. 2001), alcohol (Gardner et al.
 2000), glucose metabolism (Mittendorfer 2005), and patterns of adiposity and
 energy expenditure (Legato 1997; Gardner et al. 2000). Candidate gene studies,
 which focus on genes known to affect lipoprotein metabolism, have identified
 genes associated with plasma HDL levels (Kessling et al. 1992; Acton et al.
 1999a; Pallaud et al. 2001; Ordovas 2002), with several studies reporting geno-
 type-by-sex interaction affecting HDL associated with variants of the APOA1
 (Kessling et al. 1992; Sigurdsson et al. 1992; Saha et al. 1994), APOB, and CETP
 (Kessling et al. 1992) genes. An extensive study of APOE variants now suggests
 that data combining males and females may lead to inferences about gene effects
 that do not accurately reflect true gene influence in either sex (Stengard et al.
 2002).
 We previously reported evidence for a QTL on chromosome 2q that influ-
 ences HDL variation in a longitudinal sample of female Framingham Heart Study
 participants (North et al. 2003). Although the QTL was detected in the combined
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 sample of males and females at the first time point, linkage was not significant at
 subsequent time points. These previous analyses were conducted on data fur-
 nished to the Genetic Analysis Workshop 1 3 and lacked several relevant variables
 and possibly limited the outcome. Moreover, male-specific linkage results were
 not considered. In this paper we further examine the evidence for sex-specific
 linkage of HDL in Framingham Heart Study participants and include additional
 variables that may affect genotype-by-sex variation: menopausal status, hormone
 therapy, and lipid-lowering drugs.
 Methods
 Population. The Framingham Heart Study has remained an ongoing project
 since its inception in 1948. Data collection began with 5,209 subjects (ages
 28-62 years) in 1948, and offspring of the original cohort were added in 1971
 as well as spouses. Follow-up visits occurred every two or four years for the
 cohort and offspring groups, respectively. The longitudinal study design and
 methods have been previously documented (Dawber et al. 1951; Kannel et al.
 1979). For the purpose of this study data from all participant generations were
 included from three time points, approximately 8 years apart. We assessed fasting
 HDL levels, choosing early observations to obtain maximum sample size. These
 time points, designated for this study as tu t2 , and t3 , refer to visits 11, 15, and
 20 in the original cohort and visits 1, 2, and 4 in the offspring and spouses and
 correspond to 1971-1974, 1980-1983, and 1988-1991, respectively.
 We selected individuals measured at all the exams of interest who had
 complete phenotypic data on age, sex, and cohort effects and included additional
 variables of smoking and drinking history, lipid-lowering drugs, menopause, es-
 trogen use, and BMI. Fewer than 10 outliers (defined for this study as those
 observations beyond four standard deviations from the global mean) were re-
 moved, thus reducing the effects of nonnormality or kurtosis on linkage analysis.
 Kurtosis values in visits tu t2 , and t3 were 0.3, 0.5, and 0.4, respectively, in the
 combined-sexes data. Kurtosis for males in these time periods was 0.52, 0.58,
 and 0.73 and in females, 0.43, 0.19, and 0.19, respectively. The resulting sample
 analyzed for this study included 1,562 individuals (766 males and 796 females),
 representing nearly 3,300 relative pairs in 330 pedigrees: 663 parent-offspring
 pairs, 1,273 sibling pairs, 445 avuncular pairs, and 717 pairs of first cousins.
 Genotyping. DNA was obtained from 330 Framingham Heart Study families
 (ranging in size from 2 to 7) and was sent to the Mammalian Genotyping Service
 at the Marshfield Clinic (Marshfield, Wisconsin; http://research.marshfieldclinic
 .org/genetics). Using Weber marker set 9, we constructed a 10-cM density ge-
 nome-wide map. The average heterozygosity of the sex-averaged markers for this
 population was 0.77 (Yuan et al. 1997). Genotype data cleaning was completed,
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 including verifications of family relationships and checks for Mendelian incon-
 sistencies using "sibkin" in the Aspex program (Hinds 1996) and "gentest," a
 precursor of "infer" in PEDSYS (Dyke 1994).
 To determine the physical location of significant markers and to search for
 candidate genes, we used three data banks: University of California, Santa Cruz
 (http://genomeAicsc.edu); Wellcome Trust, Sanger Institute (http ://ww w.sanger
 .ac.uk/); and Online Mendelian Inheritance in Man (http://www3.ncbi.nlm.nih
 .gov/entrez/query.fcgi?db = OMIM).
 Phenotyping. To determine HDL levels, we collected blood samples after a
 12-hr fast in tubes containing 0.1% EDTA. Plasma was separated by centrifuga-
 tion, and lipids were immediately analyzed. HDL was measured after precipitat-
 ing out non-HDL lipoproteins (those containing apolipoprotein B) with dextran
 sulfate and magnesium sulfate (Ordovas et al. 2002).
 Additional data were collected through standardized questionnaires. Meno-
 pause was defined as the cessation of menstrual periods for more than 1 year.
 Hormone replacement therapy was defined as the use of oral Premarin or patch
 estrogen. Information was also available on the use of lipid-lowering drugs.
 Drinking history was documented as the typical amount (in grams) of alcohol
 consumed per day during the year before the examination. Smoking history was
 defined as the typical number of cigarettes smoked per day during the 1 year
 before the date of examination (Gebara et al. 1995; Saccone et al. 2003).
 Analysis
 Covariate Adjustment. Descriptive statistics and stepwise multivariate re-
 gression were calculated using SPSS 10 to determine significant covariates of
 HDL to be considered in the genetic model. Subsequently, using SOLAR, version
 2.1.2, we screened for statistically significant covariates from a list of covariates
 that have been shown to affect HDL variation: age, age by sex, cohort, BMI,
 drinking and smoking histories, blood pressure, lipid-lowering medications,
 menopause status, and estrogen therapy (Stevens et al. 1993; Perusse et al. 1997a;
 Friedlander et al. 2000; Wu and von Eckardstein 2003). We retained those covari-
 ates whose effects were significant at a/? ^ 0.10 in the initial analysis, regardless
 of whether the significance levels decreased after inclusion of other covariates.
 We constructed two models for comparison, one using a minimum adjustment
 strategy (adjusting for age, age squared, age-by-sex, and cohort effects) and the
 second model adjusted for BMI, smoking and drinking history, lipid-lowering
 drugs, menopause, and estrogen therapy for women, or BMI, smoking and drink-
 ing history, and lipid-lowering drugs for men.
 Genotype-by-Sex Interaction. To examine the evidence for genotype-by-sex
 interaction on HDL levels, we used a three-step approach. We first tested for
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 evidence of additive genotype-by-sex interaction in the polygenic model. Second,
 we compared the results from a linkage analysis of males and females (sex-
 stratified subsets) to the results of an analysis including both males and females
 (combined sample) to restrict the number of regions considered in the QTL-
 specific genotype-by-sex interaction analysis. Last, we examined the evidence for
 a QTL-specific genotype-by-sex interaction at regions identified in the linkage
 analysis. SOLAR version 2.1.2 was used for all quantitative genetic analyses
 (Almasy and Blangero 1998).
 Additive Genotype-by-Sex Interaction. Univariate quantitative genetic anal-
 ysis was done to partition the phenotypic variance of HDL into its additive sex-
 specific genetic and environmental components using maximum-likelihood vari-
 ance decomposition methods (Robertson 1959; Eisen and Legates 1966; Comuz-
 zie et al. 1993). The expected genetic covariance between a male and female
 relative pair /, j is defined as
 Cov(gt Af, gjF) = 2(f>ijpg(M F)(jgMcrg F (1)
 where 0 is the coefficient of kinship between the two individuals, pg{M,F) is the
 additive genetic correlation between the expressions of the trait in the two sexes,
 and agM and ag F are the respective genetic standard deviations for males and
 females, respectively. In the absence of additive genotype-by-sex interaction (i.e.,
 the null hypothesis), the genetic correlation between male and female relative
 pairs should be pg(M,F ) - 1.0, and male and female genetic standard deviations
 will be identical ( crgM = crgtF). Conversely, if there is additive genotype-by-sex
 interaction, the genetic correlation between the sexes will be significantly less
 than 1.0 and/or the genetic standard deviations will not be equal between the
 sexes. The likelihood of the model including an additive genotype-by-sex interac-
 tion was compared to the likelihood of the restricted model in which such interac-
 tion was excluded using a likelihood-ratio test.
 Variance Components Linkage Analysis. To identify regions of the genome
 of genotype-by-sex interaction, we completed a multipoint scan across the auto-
 somes, in the combined-sexes sample, and also in samples stratified by sex. Re-
 gions of interest were identified as those with LOD scores greater than or equal
 to 1.77 (suggestive evidence for linkage; Rao and Gu 2001) and those regions
 that appeared to differ by sex. Genome scans for HDL were performed using
 both covariate adjustment strategy models at each of the three time points. To
 estimate multipoint identical-by-descent probabilities, a pairwise maximum-like-
 lihood-base procedure was used, with an extension of Fulker and Cherny's
 (1996) technique, to permit the multipoint analysis for quantitative trait (QTL)
 mapping (Almasy and Blangero 1998). Using a variance component model
 (Blangero and Almasy 1997), we tested the null hypothesis that the additive ge-
 netic variance resulting from a QTL (cr^) equals 0 (no linkage) by comparing the
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 likelihood of this restricted model with that of a model in which a2q is estimated.
 The difference between the two log10-likelihoods produces a LOD score that is
 the equivalent of the classical LOD score of linkage analysis. Twice the differ-
 ence in log-likelihoods of these models yields a test statistic that is asymptoti-
 cally distributed as a ^ ^ mixture of a chi-square variable and a point mass at 0
 (Hopper and Mathews 1982).
 To verify our major linkage findings, we calculated the adjusted distribution
 of the LOD scores under the assumption of multivariate normality, using 10,000
 replicates and simulation methods incorporated into SOLAR (Almasy and Blan-
 gero 1998). We then used the adjusted distribution of the simulated LOD scores
 to assign percentiles to each replicate and calculated an expected test statistic on
 the basis of the percentile. SOLAR produces a correction constant by regressing
 the expected LOD scores on the observed simulated LOD scores, which we used
 to determine an adjusted LOD score [adjusted LOD score = observed LOD
 score X correction constant (Blangero et al. 2001)]. All correction constants were
 0.88 or greater.
 QTL-Specific Genotype-by-Sex Interaction. In the regions identified by
 comparison of genome scans of males, females, and the combined-sexes sample,
 we extended the additive genotype-by-sex interaction to include a QTL-specific
 component by including two more parameters: the QTL-specific standard devia-
 tion for males and for females (Towne et al. 1999). The expected genetic covari-
 ance between a male and female relative pair /, j is defined as
 Cov(gi Af, gjF) = 2(f>ijpg(MtF)crg Mcrg F 4- 7rqiJcrqMcrqF (2)
 where 7rqij is the probability that individuals i and j are identical by descent at a
 QTL that is linked to a genetic marker locus, and aq M and aq F are the marker-
 specific genetic standard deviations for males and females, respectively. To test
 for QTL-specific genotype-by-sex interaction, we compared the likelihood of the
 model in which the male and female marker-specific standard deviations are con-
 strained to be equal {crqM = aq>F) (i.e., the null hypothesis) to the likelihood of a
 general model in which all additive and QTL-specific parameters are estimated.
 Using a chi-square test with 1 degree of freedom, we compared the likelihood of
 this model including a QTL-specific genotype-by-sex interaction to the likeli-
 hood of the restricted model in which such interaction was excluded using a
 likelihood-ratio test (Self and Liang 1987; Williams et al. 1999a, 1999b).
 Results
 Descriptive Statistics. HDL levels were consistently lower in males than in
 females in both cohorts over all three time periods (Table 1). HDL levels and age
This content downloaded from 140.160.178.140 on Fri, 01 Mar 2019 18:31:26 UTC




























































 ig On ON 00
 c[ -S ë c ö ëôci
 F* tj-ON^O r-«rj(N




 § 3* ? ? ?
 EiQ w www





 § ^ ^ ^
 00 ^ ^ #
 "ïï 2 en r» (N
 § ^ m Tf 'o
 3 N_ WWW
 Q C CN <N
 cv md r- O
 Q» <n m Tf
 s
 1
 Sa ^ m ^ n Tt TJ m Tt in i/^
 S h 'o h "O h h 'o m h ^ h 'o
 »^§ <N<N<N<N<N<N N (N M M M M
 Îr
 (N - Tt o Tj- - IT) Tt Tj- (N Tt m
 è§ vo^tiorocNm oot^iriTt - u-)
 *«j ^t Tt rt Tt rt in ir> m in m in
 I
 ÏÏQ ^
 a co ^o^o^o ^o^o^o
 wOwwwC- wOwwwO
 w <3 r-~ m m - in m ^"sf-io<Nroo'
 in m vo r- TJ- mm^OTtr-Tj-
 ûc
 rÇ <
 _ h on h o> h on - < m - < i/o - < ^
 _ R ^j- - I Tt -H Tt -H O ON O ON O ON
 ^ VO 'û - >>0 (N T) (N IT) N •/!
 CA CA CA CA Yl CA
 <u <u <u <u ^ <u
 ca ca ca ca i£ ca
 3 =3 3 3 £ 3
 &> o o o o g o
 «Si &> Oh CI| OH OH r£< O. ca ça i/5 ca C/j ca
 s "ôû ~bi) "5Û ~5î) ~5i) ~Bi)
 a _ccc c c c
 ti "C ti 'C tî 'C ti 'C t 'C s 'C
 OOhoCXOOl- OCXOC^OO-
 ä OOhoCXOOl- <£ -c <£ -c <£ .c OCXOC^OO- £ Je <£ .c <£





 •tS C - ♦£? *£? C S ^ - ^ ^
 2 S £
 Genotype-by-Sex Interaction and HDL / 779
This content downloaded from 140.160.178.140 on Fri, 01 Mar 2019 18:31:26 UTC
All use subject to https://about.jstor.org/terms
 780 / MOSHER ET AL.
 Visit Sample Heritability (± SE)
 ti Males3 0.62 ±0.10
 Females3 0.48 ±0.10
 Combined13 0.42 ± 0.05
 t2 Males 0.50 ±0.10
 Females 0.41 ±0.10
 Combined 0.42 ± 0.05
 h Males 0.51 ± 0.09
 Females 0.38 ± 0.09
 Combined 0.42 ± 0.05
 a. Adjusted for age, age2, and cohort.
 b. Adjusted for age, age2, age by sex, age2 by sex, and cohort.
 were not statistically associated in males; however, HDL was positively associ-
 ated with age in females at t' (p = 0.001) and negatively associated with age in
 females at t3(p = 0.003). Males and females in the original cohort were margin-
 ally overweight, as illustrated by the mean BMI, whereas the offspring females in
 tx and t2 were within the normal range (21-25). Although the number of females
 reporting menopause in t3 was double that in tu the number of females reporting
 taking estrogen was consistently low, at approximately 5%. In addition, the per-
 centage of both males and females taking lipid-lowering medications was low,
 less than 3.4% for all time periods in both males and females.
 After accounting for covariates, there was strong residual heritability of
 HDL in the combined-sexes sample, in males, and in females (Table 2). Residual
 heritability was similar at all time points. Adjustment for BMI, smoking and
 drinking history, lipid-lowering drugs, menopause status, and estrogen therapy
 for women, and BMI, smoking and drinking history, and lipid-lowering drugs
 for men changed the heritabilities only slightly ( ± < 0.05) (data not shown).
 Additive Genotype-by-Sex Interaction. We found evidence for genotype-
 by-sex interactions for HDL at all three time points, with genetic standard devia-
 tions larger in males than in females. The model in which the genetic correlation
 between males and females ( pg(M,F ) = 1-0) was constrained to 1.0 was signifi-
 cantly different from the general model in which this correlation was estimated
 (pg = 0.003 ± 0.10 for tl9 pg = 0.11 ± 0.11 for t2, and pg = 0.07 ± 0.11 for r3;
 all P <0.001). The implication is that there are some distinct additive genetic
 effects on HDL in males and females. Moreover, the fit of the model in which
 the male and female genetic standard deviations were constrained to be equal
 was significantly different from the fit of the general model in which
 such interaction was allowed for tx ( cr2gF = 11.0 ± 0.95, a2gM = 14.89 ± 1.13,
 P ^ 0.03) and t2 = 9.80 ± 0.89, = 12.99 ± 1.04, P ^ 0.04) only. The
 Table 2. Residual Heritability for HDL in Males, Females, and the Combined-Sexes
 Sample
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 Table 3. Adjusted LOD Scores > 1 .T for HDL Across Three Time Points in the Com-
 bined-Sexes Sample and Stratified by Sex
 Visit Sample Chromosome Locus Adjusted LOD Score
 1 1 Femalesb 2 133 2.6
 Females 12 170 1.8
 Combined0 2 150 3.1
 Combined 12 170 2.1
 t2 Males 16 79 2.2
 Combined 1 12 2.2
 f3 Males 18 75 2.4
 Females 2 132 2.1
 a. Criteria for suggestive evidence of linkage according to Rao and Gu (2001).
 b. Sex-stratified analysis adjusted for age, age2, and cohort.
 c. Analysis of combined data adjusted for age, age2, age by sex, age2 by sex, and cohort.
 implication is that the magnitude of genetic effects on HDL is different in males
 and females.
 Variance Components Linkage Analysis. Table 3 presents the adjusted LOD
 scores from our multipoint genome- wide scan using the minimum model and the
 location for all peaks greater than or equal to 1.77. Only the results using the
 minimum adjustment strategy are presented, because the adjusted LOD scores
 obtained using the Model 2 adjustment strategy were similar. Although the heri-
 tability of HDL is not significantly different in males and females, sex does
 appear to exert a substantial effect on the QTL-specific variance of HDL.
 In the combined-sexes sample we obtained an adjusted LOD score of 3.1
 on chromosome 2 at 150 cM for the tx observation. At t2 and t3 this region did
 not reach statistical significance, with adjusted LOD scores of 0.5 at 120 cM and
 1.0 at 122 cM, respectively. Two other signals in the combined-sexes sample
 reached statistical significance: At tx the adjusted LOD score was 2.1 on chromo-
 some 12 at 170 cM, and at t2 the adjusted LOD score was 2.2 on chromosome 1
 at 12 cM.
 However, when stratifying the sample by sex, we documented a consistent
 finding of linkage in females on chromosome 2 near marker D2S1328 at 2ql4.3
 in all three time periods, with adjusted LOD scores of 2.6 at tu 1.7 at t2 , and 2.1
 at t3 (Figure 1). The one LOD unit support interval (SI) of the chromosome 2
 signal in females spans 39 cM and 47 MB. A second location suggestive of
 linkage was identified on chromosome 12, near marker D12S392, with an ad-
 justed LOD score of 1.8 at and the SI spanning 25 cM (Figure 2). In the male
 subset no linkage was detected in either of these regions (data not shown); how-
 ever, at 170 cM an adjusted LOD score of 2.1 was detected on chromosome 12
 in the combined-sexes sample.
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 Figure 1. Adjusted LOD scores on chromosome 2 for HDL cholesterol in females and the com-
 bined-sexes sample at three time points. Data from the Framingham Heart Study.
 Figure 2. Adjusted LOD scores on chromosome 12 for HDL cholesterol in females and the com-
 bined-sexes sample at three time points. Data from the Framingham Heart Study.
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 Figure 3. Adjusted LOD scores on chromosome 16 for HDL cholesterol in males and the com-
 bined-sexes sample at three time points. Data from the Framingham Heart Study.
 In males the results are not consistent across observation time points. We
 detected an adjusted LOD score of 2.2 on chromosome 16 at 79 cM (nearest
 marker D16S3396, located at 16ql2.1) at t2 (Figure 3). The SI spans 36.5 MB.
 We also detected a suggestive linkage peak (adjusted LOD = 2.4) on chromo-
 some 18 at 75 cM (nearest marker DS18S851, located at 18q21.1) at t3 (Figure
 4). The SI spans 36 MB. No adjusted LOD scores greater than 1.0 were detected
 in females in either of these regions (data not shown); however, at 106 cM an
 adjusted LOD score of 1.7 was detected in the combined sample.
 QTL-Specific Genotype-by-Sex Interaction. QTL-specific genotype-by-sex
 interaction was noted at four chromosomal locations displaying increased linkage
 signals in one of the two sex subsets (chromosomes 2, 12, 16, and 18). On chro-
 mosome 2 QTL-specific interaction was noted for all three time periods and is
 reported in Table 3 (all /)<0.03). In contrast, on chromosome 12, 16, and 18
 QTL-specific interaction was noted only at a single time point. QTL-specific
 interaction was identified on chromosome 12 for the first time point, on chromo-
 some 16 for the second time point, and on chromosome 18 for the third time
 point (all P < 0.03).
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 Figure 4. Adjusted LOD scores on chromosome 18 for HDL cholesterol in males and the com-
 bined-sexes sample at three time points. Data from the Framingham Heart Study.
 Discussion
 Sexual dimorphism in HDL levels is frequently reported in the literature
 (Reilly et al. 1990; Barrett-Conner 1997). However, most linkage studies of HDL
 levels have not explicitly explored genotype-by-sex interaction by testing
 whether the genes influencing HDL variability are differentially expressed in
 males and females. Therefore our objective was to examine the evidence for
 sex- specific linkage of HDL in a longitudinal sample of participants from the
 Framingham Heart Study. To approach this complex question, we assessed the
 evidence for additive genotype-by-sex interaction. In addition, we identified four
 regions on the genome that displayed differential evidence of linkage in males
 and females. By examining these regions further, we demonstrated sex-specific
 QTL effects at each of these loci.
 We found strong evidence of additive genotype-by-sex interaction in HDL
 levels across all three time periods. The male and female genetic standard devia-
 tions were significantly different for time period tu suggesting a different magni-
 tude of genetic effects on HDL in males and females. Moreover, the genetic
 correlation between males and females was significantly different from 1 across
 all three time periods (p < 0.001), suggesting distinct additive genetic effects on
This content downloaded from 140.160.178.140 on Fri, 01 Mar 2019 18:31:26 UTC
All use subject to https://about.jstor.org/terms
 Genotype-by-Sex Interaction and HDL / 785
 HDL in males and females. Based on the estimates of pg, the shared genetic
 component to the variance in HDL between the sexes in this population appears
 to be negligible. However, we must be cautious in interpreting this finding to
 specific loci because this is an estimate for additive effects, and thus the lack of
 a genetic correlation may be due to oligogenic effects that differ in the sexes
 (Carey 1988).
 In the sex-specific linkage analysis we identified four regions, only one of
 which was identified in the full sample. Although these sex-specific linkages
 exhibited only suggestive evidence, these signals overlap previously reported
 QTLs associated with HDL and related phenotypes (Table 4). Moreover, the pres-
 ence of biological candidate genes with sex-specific influence in several of these
 regions further supports our hypothesis of sex-specific loci affecting HDL varia-
 tion.
 We also found strong evidence of QTL-specific genotype-by-sex interac-
 tion, with suggestive QTLs identified in sex-stratified data on chromosomes 2q
 and 12q in females and chromosomes 16q and 18q in males. The inclusion of
 the QTL-specific genotype-by-sex component strengthens our findings from the
 linkage analysis that was performed in the sex-specific stratum, which was re-
 stricted to the relative pairs concordant for sex (826 and 808 male and female
 concordant relative pairs, respectively). When formally modeling QTL-specific
 interaction, we were able to use the information from the discordant relative pairs
 (N = 1,612), thereby increasing our power to detect genetic effects. The formal
 testing of QTL-specific genotype-by-sex interaction suggests that the underlying
 genetic structure of HDL may be sex specific. Table 5 documents our findings
 and the studies that they replicate.
 In females the strongest evidence for linkage at chromosome 2q 13.43 coin-
 cides with findings associated with lipid phenotypes in two different populations.
 This region contains several interleukin 1 (IL1) alpha and beta genes, which
 influence inflammation (Lord et al. 1991), as well as IL1 receptor antagonist,
 which inhibits IL1 action on endothelial cells (Dinarello and Wolff 1993). Sex
 hormones have been shown to influence the expression of IL1 (Morishita et al.
 1999). The second finding for females, at chromosome 12q24, also coincides
 with a signal reported for triglycerides (Reed et al. 2001). Chromosome 12q24
 harbors SCARB1, which is an HDL receptor that regulates cholesterol and tri-
 glycerides uptake (McCarthy et al. 2003; Trigatti et al. 2003; Osgood et al. 2003).
 Several studies have demonstrated sex-specific effects of this gene on lipoprotein
 variation (Acton et al. 1999b; McCarthy et al. 2003).
 In males the marker identified at chromosome 16q21.1 coincides with a
 region linked to triglycerides in the Framingham Heart Study (Shearman et al.
 2000) and several related phenotypes in Mauritian families (Francke et al. 2001).
 Our signal is also less than 20 MB from the signal reported for HDL on chromo-
 some 16q22 in Mexican American families (Mahaney et al. 2003). Chromosome
 16ql2.1 includes the CETP and LCAT genes. Both have been shown to affect
 HDL variation (Brousseau et al. 2002; Ordovas et al. 2000). Genotype-by-sex
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 effects have been documented for CETP variants in Israeli (Kark et al. 2000),
 Finnish (Kauma et al. 1996), and American (Kastelein et al. 1999) populations,
 although some studies have identified female-specific effects and others male-
 specific effects. Our second finding for males, located at chromosome 18q21.1,
 supports the results noted on chromosome 18q21.31 for lipid phenotypes in fami-
 lies recruited for the HyperGEN Study (Coon et al. 2001). Chromosome
 18q21.31 contains start-domain-containing protein 6 (STARD6), which binds
 cholesterol to the mitochondrial P450 cleavage enzymes in steroidogenic cells.
 STARD6 is identified as testis specific and is not reported in ovarian tissue. Be-
 cause STARD6 is involved in cholesterol homeostasis and is testis specific, it is
 an interesting candidate for sex-specific linkage signals.
 Differences in the genes contributing to the variation in HDL by sex or
 differences in the expression of HDL by sex are biologically plausible and are
 supported by several lines of evidence. First, sexual dimorphism in HDL levels
 is frequently reported in the literature (Reilly et al. 1990; Barrett-Conner 1997).
 Second, sex-specific QTLs that influence variation in HDL levels have been iden-
 tified in animal models (Kloting et al. 2001; Korstanje et al. 2004b). Moreover,
 sex-specific QTLs for physiologically related phenotypes, such as serum insulin,
 triglyceride, total cholesterol, and phospholipid levels, have also been reported
 (Kloting et al. 2001; Anunciado et al. 2003).
 This study has several limitations. First, there is a general lack of consis-
 tency in linkage results across time periods. One possible interpretation of these
 findings is age-dependent changes in the genetic control of HDL levels (Diego et
 al. 2003). Clearly, there is evidence of an age-related trend in the sexual dimor-
 phism of circulating HDL levels (Williams 1992; Snieder et al. 1997). Such age-
 related genetic effects are supported by the sex-specific age trends in HDL varia-
 tion. Sexual dimorphism in HDL is first noted during adolescence, when the
 concentration of HDL begins to decrease in males and increase in females. The
 differences remain throughout the life span, despite some decrease in HDL levels
 during the female menopause transition (Snieder et al. 1997; Barrett-Conner
 1997). At this time, addressing both genotype-by-sex and genotype-by-age inter-
 action together is not feasible; furthermore, this type of analysis would require
 substantially larger sample sizes to achieve appropriate statistical power. How-
 ever, the lack of consistency may also be due to stochastic variation in HDL
 levels (Diego et al. 2003), environmental factors that change over time, and tem-
 poral changes in measurement techniques. A second limitation is the lack of
 available information on dietary intake of macronutrients (proteins, fat, and car-
 bohydrate) and energy expenditure. More research to address the effects of diet,
 exercise, and age as well as an exploration of relevant candidate gene variants
 may further shed light on the underlying genetic architecture of HDL variation.
 In conclusion, this study provides strong evidence of genotype-by-sex in-
 teraction on circulating HDL levels. In the additive genetic genotype-by-sex in-
 teraction analysis, both the genetic standard deviations in males and in females
 differed significantly and the genetic correlation was significantly different from
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 1 . These results suggest that a different gene or suite of genes is contributing to
 the variance of HDL levels in this population. The inference of a suite of different
 genes influencing HDL levels in males and females is further supported by the
 variance components linkage analyses of the sample stratified by sex, where sug-
 gestive evidence for linkage to HDL was identified on two chromosomes in fe-
 males (chromosomes 2 and 12) and on two chromosomes in males (chromosomes
 16 and 18). Furthermore, we identified QTL-specific genotype-by-sex interaction
 at these four loci, suggesting a complex genetic architecture to HDL levels that
 varies by sex.
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